The Program Manager, Regulatory Affairs manages the regulatory aspects of biotechnology-derived products, including applications submitted to the FDA and other regulatory agencies. This individual will lead the US Regulatory Affairs program for development of multiple cell-based products through the clinical phases and submission of a Biologics Licensing Applications (BLA). This includes leading the preparation and submission of Investigational New Drug (IND) and BLA applications, with overall responsibility for submissions and writing of Chemistry Manufacturing Controls (CMC) sections. Working with cross functional collaborators (such as R&D and Quality) and external consultants, this individual will also advise on regulatory and scientific issues related to the development of these products. Must have proven experience with successfully leading and writing submissions and expertise in regulatory scientific aspects of biotechnology-derived products, specifically with a focus on CMC requirements.
This individual will also interface directly with governmental personnel and regulators, including scientific reviewers, administrative staff, and management to facilitate the review and approval of regulatory applications and ensure regulatory compliance. This includes preparing for and participating in meetings with FDA and the development of meeting briefing packages, in furtherance of the regulatory BLA program. This position will also provide regulatory leadership and partner with other departments (Operations, Quality, Medical, Marketing, etc.) to support multiple platforms and product lines for commercialization and post-marketing activities. This will require the development of effective proactive regulatory strategies and tactical execution of regulatory activities for product lifecycle management including product development, commercialization, and post-marketing. Will recommend such strategies to the RA Team Leader, Team Members, and/or Supervisor, as appropriate, with limited oversight. This position is based at Organogenesis's headquarters in Canton, MA. Limited overnight travel may be required.
Responsible for regulatory submissions for bio-technology products including cell-based and tissue derived products. Includes preparation writing and submission of IND and BLA applications as well as other submission types for products approved/cleared through PMA and 510(k) pathways. Ensure that regulatory submissions are complete, properly formatted, and comply with applicable regulatory requirements.
Research regulatory and scientific information to develop regulatory strategies and provide input on technical issues (e.g. review validation and testing strategies and reports) to guide internal teams.
Interact with government agencies and regulatory authorities, as necessary, to facilitate submission review and product approvals, maintain compliance and communicate pertinent information. Plan and participate in meetings with FDA and provide regulatory support for inspections by government and other regulatory authorities.
Develop and manage project plans to meet Company objectives and further business. Provide regulatory insight to inform business planning and strategies.
Partner with other functional areas (including Manufacturing, Quality, Marketing, Medical and Clinical Affairs, Customer Service, Legal and Compliance, Health Policy and Reimbursement) to deliver solutions to business problems and execute tactics that further business objectives in an effective and compliant manner.
Monitor, identify and communicate new and relevant changes in applicable regulations, guidance, standards, other applicable regulatory policies. Provides insight to Regulatory Department and cross-functional teams to ensure compliance with new requirements and promote continuous improvement and current best-practices
Collaborate with Quality Systems to manage and maintain compliance of systems and processes with GMP/ QSR requirements, applicable international requirements and industry standards. Development, writing and review of SOPs and protocols to ensure regulatory compliance.
Participates in activities such as product design and development, risk assessments, evaluation of quality events and non-conformancies, evaluation of change controls, validation and testing; determine impact on submissions and filing requirements.
Participate in industry organizations and alliances to influence regulatory policy making and decisions that impact company operations.
Lead/manage complex issues with multiple competing priorities that have a direct impact on operations and opportunities. Provide organization and prioritization to align with business needs.
Interact with outside consulting groups and vendors to manage activities necessary for completing key initiatives.
ABILITIES AND SKILLS REQUIRED:
Strong oral and written communication skills, and negotiation skills
Willing to set and drive aggressive project timelines
Capable of strategic thinking and proposing innovative solutions to regulatory problems
A team player, who listens effectively
Bachelor’s degree in a scientific discipline
At least 10 years' experience in the medical or life science industry with at least five years of increasingly responsible experience in Regulatory Affairs
Solid working knowledge of device/biologic development process and of FDA regulatory requirements for biotechnology products in the U.S. required
Must have successfully submitted regulatory filings to the FDA and other regulatory agencies. Experience working on INDs and BLA submissions strongly preferred
Experience with technical aspects of product development and manufacturing
Internal Number: 326
About Organogenesis, Inc.
Organogenesis Inc. is a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company’s mission is to provide integrated healing solutions that substantially improve medical outcomes and the lives of patients while lowering the overall cost of care.
Organogenesis' versatile product portfolio is designed to treat a variety of patients with repair and regenerative needs across the continuum of care.
Organogenesis Inc. was originally founded in 1985 as a spin-off of technology developed at the Massachusetts Institute of Technology (MIT). In 2017, Organogenesis acquired NuTech Medical, which further expanded our wound care portfolio and introduced product solutions for the surgical and sports medicine markets.
Today, Organogenesis has approximately 600 employees worldwide and is led by a management team of talented individuals with more than 100 years of collective regenerative medicine experience. The Organogenesis corporate headquarters is located on our four-building campus in Canton, Massachusetts.